Position in ABVX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$1,075,529
+$30,403 QoQ
Shares Held
9,659
+24.6% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ABVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026HIMENSION CAPITAL (SINGAPORE) PTE. LTD. holds $21,104,538 across 9 Biotechnology names. ABVX ranks #6 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTLA |
Intellia Therapeutics, Inc.
|
429,540 | $5,506,702 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
92,481 | $4,399,321 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
13,169 | $4,357,227 | |
| 4 | MRNA |
Moderna, Inc.
|
35,338 | $1,795,170 | |
| 5 | BEAM |
Beam Therapeutics Inc.
|
62,089 | $1,479,580 | |
| 6 | ABVX |
Abivax S.A.
This page
|
9,659 | $1,075,529 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
10,805 | $1,050,786 | |
| 8 | RLAY |
Relay Therapeutics, Inc.
|
94,169 | $936,981 |
All Filings in ABVX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,075,529 | 9,659 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,045,126 | 7,750 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,015,573 | 11,962 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||